Meghana Keshavan covers biotechnology industry trends for STAT.
She has written about the life sciences industry for nearly a decade. Before that, she worked for news outlets like Thomson Reuters, the Detroit Free Press, the Detroit Metro Times and NPR affiliate WDET.
As a young lass, Meghana toiled five years as a research peon in a schizophrenia genetics lab. She once spilled ethidium bromide on herself, and might be a mutant.